Abstract
Successful disease prevention and therapy critically depend on timely diagnosis of infections. Quantitative immuno-PCR (qiPCR) technology improves the sensitivity in the detection of antibodies to pathogens. A qiPCR-based assay was developed to determine IgG antibodies to Epstein–Barr virus (EBV) in the human blood serum. EBV nuclear protein 1 fragment (pEBV) was expressed in Escherichia coli. A synthetic single-stranded deoxyribonucleotide was conjugated to streptavidin, and the conjugate was used to detect рEBV–IgG1–biotin complexes by qiPCR. The IgG1 titers determined by qiPCR were compared to the results of enzyme-linked immunosorbent assay (ELISA). The sensitivity of qiPCR was one order of magnitude higher than that of ELISA. Thus, a highly sensitive qiPCR-based assay was developed to quantitate antibodies specific to the recombinant EBV antigen.
Similar content being viewed by others
Abbreviations
- ELISA:
-
enzyme-linked immunosorbent assay
- EBNA1:
-
Epstein–Barr nuclear antigen 1
- EBV:
-
Epstein–Barr virus
- IgG1:
-
immunoglobulin G1
- iPCR:
-
immuno-PCR
- qiPCR:
-
quantitative iPCR
- sODN:
-
streptavidin–oligodeoxyribonucleotide complex
References
Ryazantsev D.Y., Voronina D.V., Zavriev S.K. 2016. Immuno-PCR: Achievements and perspectives. Biochemistry (Moscow). 81, 1754–1770.
Chang L., Li J., Wang L. 2016. Immuno-PCR: An ultrasensitive immunoassay for biomolecular detection. Anal. Chim. Acta. 910, 12–124.
Jani D., Savino E., Goyal J. 2015. Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodies. Bioanalysis. 7, 285–294.
Mweene A.S., Ito T., Okazaki K., Ono E., Shimizu Y., Kida H. 1996. Development of immuno-PCR for diagnosis of bovine herpesvirus 1 infection. J. Clin. Microbiol. 34, 748–750.
Halpern M.D., Jain S., Jewett M.W. 2013. Enhanced detection of host response antibodies to Borrelia burgdorferi using immuno-PCR. Clin. Vaccine Immunol. 20, 350–357.
Spengler M., Adler M., Jonas A., Niemeyer C. 2009. Immuno-PCR assays for immunogenicity testing. Biochem. Biophys. Res. Commun. 387, 278–282.
Morin I., Askin S.P., Schaeffer P.M. 2011. IgG-detection devices for the Tus-Ter-lock immuno-PCR diagnostic platform. Analyst. 136, 4815–4821.
Chia-Ching L., Subramaniam S., Sivasubramanian S., Feng-Huei L. 2016. MWCNT-Fe3O4-based immuno- PCR for the early screening of nasopharyngeal carcinoma. Mater. Sci. Eng. C. Mater. Biol. Appl. 61, 422–428.
Singh N., Sreenivas V., Gupta K.B., Chaudhary A., Mittal A., Varma-Basil M., Prasad R., Gakhar S.K., Khuller G.K., Mehta P.K. 2015. Diagnosis of pulmonary and extrapulmonary tuberculosis based on detection of mycobacterial antigen 85B by immuno-PCR. Diagn. Microbiol. Infect. Dis. 83, 359–364.
Rymbai M.L., Ramalingam V.V., Samarasan I., Chandran B.S., Mathew G., Jerobin J., Abraham A.M., Sachithanandham J., Kannangai R. 2015. Frequency of Epstein-Barr virus infection as detected by messenger RNA for EBNA 1 in histologically proven gastric adenocarcinoma in patients presenting to a tertiary care center in South India. Indian J. Med. Microbiol. 33, 369–373.
Kayamba V., Monze M., Asombang A.W., Zyambo K., Kelly P. 2016. Serological response to Epstein-Barr virus early antigen is associated with gastric cancer and human immunodeficiency virus infection in Zambian adults: A case-control study. Pan. Afr. Med. J. 23, 45.
Banko A.V., Lazarevic I.B., Folic M.M., Djukic V.B., Cirkovic A.M., Karalic D.Z., Cupic M.D., Jovanovic T.P. 2016. Characterization of the variability of Epstein- Barr virus genes in nasopharyngeal biopsies: Potential predictors for carcinoma progression. PLoS One. 11, e0153498.
Frappier L. 2015. EBNA1. Curr. Top. Microbiol. Immunol. 391, 3–34.
Myhr K.M., Riise T., Barrett-Connor E., Myrmel H., Vedeler C., Grønning M., Kalvenes M.B., Nyland H. 1998. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: A population based case-control study from western Norway. Neurol. Neurosurg. Psychiatry. 64, 539–542.
Lomakin Y., Arapidi G.P., Chernov A., Ziganshin R., Tcyganov E., Lyadova I., Butenko I.O., Osetrova M., Ponomarenko N., Telegin G, Govorun V.M., Gabibov A., Belogurov A., Jr. 2017. Exposure to the Epstein-Barr viral antigen latent membrane protein 1 induces myelinreactive antibodies in vivo. Front Immunol. 8, 777, 1–11.
Piroozmand A., Haddad Kashani H., Zamani B. 2017. Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: A cross-sectional study. Asian Pac. J. Cancer Prev. 18, 523–527.
Pan R., Liu X., Zhou S., Ning Z., Zheng H., Gao M., Ding Y., Yao W., Liao X., He N. 2017. Differential prevalence and correlates of whole blood Epstein-Barr virus DNA between HIV-positive and HIV-negative men who have sex with men in Shanghai, China. Epidemiol. Infect. 145, 2330–2340.
Lindsey J.W., de Gannes S.L., Pate K.A., Zhao X. 2016. Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L. Mol. Immunol. 69, 7–12.
Lindsey J.W. 2017. Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins. Neuroimmunology. 310, 131–134.
Al Sidairi H., Binkhamis K., Jackson C., Roberts C., Heinstein C., MacDonald J., Needle R., Hatchette T.F., LeBlanc J.J. 2017. Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm. J. Med. Microbiol. 66 (11), 1628–1634. doi 10.1099/jmm.0.000616
Maylin S., Feghoul L., Salmona M., Herda A., Mercier-Delarue S., Simon F., Legoff J. 2017. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation. Med. Virol. 89, 2003–2010.
Maerle A.V., Voronina D.V., Dobrochaeva K.L., Galanina O.E., Alekseev L.P., Bovin N.V., Zavriev S.K., Ryazantsev D.Y. 2017. Immuno-PCR technology for detection of natural human antibodies against Le(c) disaccharide. Glycoconj. J. 34 (32), 199–205.
Svirshchevskaya E., Fattakhova G., Khlgatian S., Chudakov D., Kashirina E., Ryazantsev D., Kotsareva O., Zavriev S. 2016. Direct versus sequential immunoglobulins switch in allergy and antiviral responses. Clin. Immunol. 170, 31–38.
Loebel M., Eckey M., Sotzny F., Hahn E., Bauer S., Grabowski P., Zerweck J., Holenya P., Hanitsch L.G., Wittke K., Borchmann P., Rüffer J.U., Hiepe F., Ruprecht K., Behrends U., et al. 2017. Serological profiling of the EBV immune response in chronic fatigue syndrome using a peptide microarray. PLoS One. 12, e0179124.
Simon K.C., Saghafian-Hedengren S., Sverremark-Ekström E., Nilsson C., Ascherio A. 2012. Age at Epstein-Barr virus infection and Epstein-Barr virus nuclear antigen-1 antibodies in Swedish children. Mult. Scler. Relat. Disord. 1 (3), 136–138.
Fachiroh J., Schouten T., Hariwiyanto B., Paramita D.K., Harijadi A., Haryana S.M., Ng M.H., Middeldorp J.M. 2004. Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: A comparison of Indonesian, Chinese, and European subjects. J. Infect. Dis. 190, 53–62.
Nociti V., Frisullo G., Marti A., Luigetti M., Iorio R., Patanella A.K., Bianco A., Tonali P.A., Grillo R.L., Sabatelli M., Batocchi A.P. 2010. Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. J. Neuroimmunol. 225, 149–152.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.D. Pivovarov, D.Yu. Ryazantsev, M.A. Simonova, T.V. Yegorova, S.V. Khlgatian, S.K. Zavriev, E.V. Svirshchevskaya, 2018, published in Molekulyarnaya Biologiya, 2018, Vol. 52, No. 4, pp. 727–734.
Rights and permissions
About this article
Cite this article
Pivovarov, V.D., Ryazantsev, D.Y., Simonova, M.A. et al. Immuno-PCR Assay for Quantitation of Antibodies to Epstein–Barr Virus. Mol Biol 52, 629–635 (2018). https://doi.org/10.1134/S0026893318040155
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893318040155